574 related articles for article (PubMed ID: 30261168)
1. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
2. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
3. The rapidly advancing Class 2 CRISPR-Cas technologies: A customizable toolbox for molecular manipulations.
Wang J; Zhang C; Feng B
J Cell Mol Med; 2020 Mar; 24(6):3256-3270. PubMed ID: 32037739
[TBL] [Abstract][Full Text] [Related]
4. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
Ishino Y; Krupovic M; Forterre P
J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
[TBL] [Abstract][Full Text] [Related]
5. Type II anti-CRISPR proteins as a new tool for synthetic biology.
Zhang Y; Marchisio MA
RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
[TBL] [Abstract][Full Text] [Related]
6. A Type IV-A CRISPR-Cas System in
Crowley VM; Catching A; Taylor HN; Borges AL; Metcalf J; Bondy-Denomy J; Jackson RN
CRISPR J; 2019 Dec; 2(6):434-440. PubMed ID: 31809194
[TBL] [Abstract][Full Text] [Related]
7. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
8. Finally, Archaea Get Their CRISPR-Cas Toolbox.
Gophna U; Allers T; Marchfelder A
Trends Microbiol; 2017 Jun; 25(6):430-432. PubMed ID: 28391963
[TBL] [Abstract][Full Text] [Related]
9. Controlling and enhancing CRISPR systems.
Shivram H; Cress BF; Knott GJ; Doudna JA
Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
[TBL] [Abstract][Full Text] [Related]
10. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
Liu T; Pan S; Li Y; Peng N; She Q
Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
12. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
13. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
[TBL] [Abstract][Full Text] [Related]
14. CRISPRCasTyper: Automated Identification, Annotation, and Classification of CRISPR-Cas Loci.
Russel J; Pinilla-Redondo R; Mayo-Muñoz D; Shah SA; Sørensen SJ
CRISPR J; 2020 Dec; 3(6):462-469. PubMed ID: 33275853
[TBL] [Abstract][Full Text] [Related]
15. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
17. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
18. Exploration of Microbial Diversity to Discover Novel Molecular Technologies.
Zhang F
Keio J Med; 2019; 68(1):26. PubMed ID: 30905885
[TBL] [Abstract][Full Text] [Related]
19. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
20. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
Hwang S; Maxwell KL
J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
